WHO ICTRP trial
Evaluation of Mandoorathy Mathirai (MM) for Jaundice
CTRI/2025/05/087611 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2025/05/087611 |
|---|---|
| Public title | Evaluation of Mandoorathy Mathirai (MM) for Jaundice |
| Scientific title | Preclinical and clinical evaluation of Mandoorathy Mathirai for the management of Hepatitis - An Open Labelled Phase-II Trial - NIL |
| Primary sponsor | Dr B Manikandan |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | India |
| Conditions | Health Condition 1: K77- Liver disorders in diseases classified elsewhere |
| Interventions | Intervention1: Mandoorathy Mathirai (MM): Mandoorathy Mathirai (MM) 1 Tab (130 mg) Twice a day for 20 days Control Intervention1: NIL: NIL |
| Registration date | May 26, 2025 |
| Target size | 20 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: